Medicare part D and quality of prescription medication use in older adults

Drugs and Aging

Volumn 28, Issue 10, 2011, Pages 797-807

  Lau, Denys T ^a   Briesacher, Becky A ^b   Touchette, Daniel R ^a   Stubbings, Joann ^a   Ng, Judy H ^c,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c NATIONAL COMMITTEE FOR QUALITY ASSURANCE   (United States)

^d PRINCETON UNIVERSITY   (United States)

Author keywords

Elderly; Health insurance; Prescribing

Indexed keywords

GENERIC DRUG;

DRUG BIOAVAILABILITY; DRUG COST; DRUG MONITORING; DRUG OVERDOSE; DRUG PROGRAM; DRUG SURVEILLANCE PROGRAM; DRUG UNDERDOSE; DRUG USE; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; MEDICARE; NURSING HOME PATIENT; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TREATMENT REFUSAL;

AGED; HUMANS; MEDICARE PART D; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; PRESCRIPTION DRUGS; QUALITY CONTROL; UNITED STATES;

EID: 80053917280     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11595250-000000000-00000     Document Type: Review

References (53)

1. The Henry J. Kaiser Family Foundation.Medicare: a primer. April 2010. Washington, DC: The Henry J. Kaiser Family Foundation, 2010 [online]. Available from URL: http:// www.kff.org/medicare/upload/7615-03.pdf [Accessed 2011 Mar 31]
2. Hoadley J, Cubanski J, Hargrave E, et al. part D plan availability in 2011 and key changes since 2006.Washington, DC: The Henry J. Kaiser Family Foundation, 2010 Oct [online]. Available from URL: http://www.kff.org/medicare/ upload/ 8107.pdf [Accessed 2011Mar 31]
3. The Henry J. Kaiser Family Foundation. Medicare fact sheet: the Medicare prescription drug benefit. Washington, DC: The Henry J. Kaiser Family Foundation, 2006 Nov [online]. Available from URL: http://www.kff.org/medi care/upload/7044-05.pdf [Accessed 2011 Mar 31]
4. Hoadley J, Thompson J, Hargrave E, et al. Medicare part D 2009 data spotlight: the coverage gap. Washington, DC: The Henry J. Kaiser Family Foundation, 2008 Aug [online]. Available from URL: http://www.kff.org/medicare/ upload/7834.pdf [Accessed 2011 Mar 31]
5. The Henry J. Kaiser Family Foundation. Explaining health care reform: key changes to theMedicare PartDdrug benefit coverage gap.Washington, DC: The Henry J.Kaiser Family Foundation, 2010Mar [online].Available fromURL: http:// www.kff.org/healthreform/upload/8059.pdf [Accessed 2011 Mar 31]
6. Polinski JM, Kilabuk E, Schneeweiss S, et al. Changes in drug use and out-of-pocket costs associated with Medicare part D implementation: a systematic review. J Am Geriatr Soc 2010 Sep; 58 (9): 1764-79
7. Lichtenberg FR, Sun SX. The impact of Medicare part D on prescription drug use by the elderly. Health Aff (Millwood) 2007 Nov-Dec; 26 (6): 1735-44
8. Safran DG, Strollo MK, Guterman S, et al. Prescription coverage, use and spending before and after part D implementation: a national longitudinal panel study. J Gen Intern Med 2010 Jan; 25 (1): 10-7
9. Schneeweiss S, Patrick AR, Pedan A, et al. The effect of Medicare part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood) 2009 Mar-Apr; 28 (2): w305-16
10. Yin W, Basu A, Zhang JX, et al. The effect of the Medicare part D prescription benefit on drug utilization and expenditures. Ann Intern Med 2008 Feb 5; 148 (3): 169-77
11. Briesacher BA, Zhao Y,Madden JM, et al. Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007. Med Care 2011 Sep; 49 (9): 834-41
12. Madden JM, Graves AJ, Ross-Degnan D, et al. Cost-related medication nonadherence after implementation of Medicare part D, 2006-2007. JAMA 2009 Oct 28; 302 (16): 1755-6
13. Neuman P, Cubanski J. Medicare part D update: lessons learned and unfinished business. N Engl JMed 2009 Jul 23; 361 (4): 406-14
14. McGivney MS, Meyer SM, Duncan-Hewitt W, et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc (2003) 2007 Sep-Oct; 47 (5): 620-8
15. Smith SR, Clancy CM. Medication therapy management programs: forming a new cornerstone for quality and safety in Medicare. Am J Med Qual 2006 Jul-Aug; 21 (4): 276-9
16. DePue Jr RJ, Stubbings J, Baker DC. Medicare part D policy update and implications for 2010. Am JManag Care 2010 May; 16 (5): e117-20
17. Chassin MR. Quality of care: time to act. JAMA 1991 Dec 25; 266 (24): 3472-3
18. Chassin MR, Galvin RW. The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA 1998 Sep 16; 280 (11): 1000-5
19. Madden JM, Graves AJ, Zhang F, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare part D. JAMA 2008 Apr 23; 299 (16): 1922-8
20. Zivin K, Madden JM, Graves AJ, et al. Cost-related medication nonadherence among beneficiaries with depression following Medicare part D. Am J Geriatr Psychiatry 2009 Dec; 17 (12): 1068-76
21. Donohue JM, Zhang Y, Lave JR, et al. The Medicare drug benefit (part D) and treatment of heart failure in older adults. Am Heart J 2010 Jul; 160 (1): 159-65
22. Zhang Y, Lave JR, Donohue JM, et al. The impact of Medicare part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care 2010 May; 48 (5): 409-17
23. Bayliss EA, Ellis JL, Delate T, et al. Characteristics of Medicare part D beneficiaries who reach the drug benefit threshold in both of the first two years of the part D benefit. Med Care 2010 Mar; 48 (3): 267-72
24. Hoadley J, Hargrave E, Cubanski J, et al. The Medicare part D coverage gap: costs and consequences in 2007. Washington, DC: The Henry J. Kaiser Family Foundation, 2008 Aug [online]. Available from URL: http:// www.kff.org/medicare/ upload/7811.pdf [Accessed 2011 Mar 31]
25. Pedan A, Lu J, Varasteh LT. Assessment of drug consumption patterns for Medicare part D patients. Am J Manag Care 2009 May; 15 (5): 323-7
26. Zhang Y, Donohue JM, Newhouse JP, et al. The effects of the coverage gap on drug spending: a closer look at Medicare part D. Health Aff (Millwood) 2009 Mar-Apr; 28 (2): w317-25
27. Raebel MA, Delate T, Ellis JL, et al. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare part D. Med Care 2008 Oct; 46 (10): 1116-22
28. Cronk A, Humphries TL, Delate T, et al. Medication strategies used by Medicare beneficiaries who reach the part D standard drug-benefit threshold. Am J Health Syst Pharm 2008 Jun 1; 65 (11): 1062-70
29. Hsu J, Fung V, Price M, et al. Medicare beneficiaries' knowledge of part D prescription drug program benefits and responses to drug costs. JAMA 2008 Apr 23; 299 (16): 1929-36
30. Sun SX, Lee KY. The Medicare part D doughnut hole: effect on pharmacy utilization. Manag Care Interface 2007 Sep; 20 (9): 51-5, 59
31. Duru OK, Mangione CM, Hsu J, et al. Generic-only drug coverage in the Medicare part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study. J Am Geriatr Soc 2010 May; 58 (5): 822-8
32. Fung V, Mangione CM, Huang J, et al. Falling into the coverage gap: part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes. Health Serv Res 2010 Apr; 45 (2): 355-75
33. Gu Q, Zeng F, Patel BV, et al. part D coverage gap and adherence to diabetes medications. Am J Manag Care 2010; 16 (12): 911-8
34. Fu AZ, Tang AS, Wang N, et al. Effect of Medicare part D on potentially inappropriate medication use by older adults. J Am Geriatr Soc 2010 May; 58 (5): 944-9
35. Golden AG, Fass J, Tewary S, et al. Cost consideration by Medicare part D plans may promote the use of potentially inappropriate medications. J Am Geriatr Soc 2010 May; 58 (5): 979-81
36. The Henry J. Kaiser Family Foundation. Medicare: prescription drug coverage among Medicare beneficiaries. Data update. Washington, DC: The Henry J. Kaiser Family Foundation, 2008 Jun [online]. Available from URL: http://www.kff.org/medicare/upload/7453.pdf [Accessed 2011 Mar 31]
37. Shrank WH, Patrick AR, Pedan A, et al. The effect of transitioning to Medicare part D drug coverage in seniors dually eligible for Medicare and Medicaid. J Am Geriatr Soc 2008 Dec; 56 (12): 2304-10
38. Hall JP, Kurth NK, Moore JM. Transition toMedicare part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities. Am JManag Care 2007 Jan; 13 (1): 14-8
39. Briesacher BA, Soumerai SB, Field TS, et al. Nursing home residents and enrollment inMedicare part D. J Am Geriatr Soc 2009 Oct; 57 (10): 1902-7
40. Briesacher BA, Soumerai SB, Field TS, et al. Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes. Arch Intern Med 2010 Apr 26; 170 (8): 693-8
41. West JC, Wilk JE, Muszynski IL, et al. Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit. Am J Psychiatry 2007 May; 164 (5): 789-96
42. West JC,Wilk JE, Rae DS, et al. First-year Medicare part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients. J Clin Psychiatry 2010 Apr; 71 (4): 400-10
43. Das-Douglas M, Riley ED, Ragland K, et al. Implementation of the Medicare part D prescription drug benefit is associated with antiretroviral therapy interruptions. AIDS Behav 2009 Feb; 13 (1): 1-9
44. Motheral BR. Pharmaceutical step-therapy interventions: a critical review of the literature. J Manag Care Pharm 2011 Mar; 17 (2): 143-55
45. Donohue JM, Frank RG. Estimating Medicare part D's impact on medication access among dually eligible beneficiaries with mental disorders. Psychiatr Serv 2007 Oct; 58 (10): 1285-91
46. Afendulis CC, He Y, Zaslavsky AM, et al. The impact of Medicare part D on hospitalization rates. Health Serv Res 2011 Aug; 46 (4): 1022-38
47. Huskamp HA, West JC, Rae DS, et al. part D and dually eligible patients with mental illness: medication access problems and use of intensive services. Psychiatr Serv 2009 Sep; 60 (9): 1169-74
48. Pellegrino AN, Martin MT, Tilton JJ, et al. Medication therapy management services: definitions and outcomes. Drugs 2009; 69 (4): 393-406
49. Moczygemba LR, Barner JC, Brown CM, et al. Patient satisfaction with a pharmacist-provided telephone medication therapy management program. Res Social Adm Pharm 2010 Jun; 6 (2): 143-54
50. Pharmacy Quality Alliance. PQA announces official launch of demonstration projects [media release]. 2008 Jul 19 [online]. Available from URL: http://www.pqaalliance.org/files/ PQALaunchofDemoProjectsJuly2008.pdf [Accessed 2011 Mar 31]
51. Zhang Y, Baicker K, Newhouse JP. Geographic variation in the quality of prescribing. N Engl J Med 2010 Nov; 363 (21): 1985-8
52. Hargrave E, Hoadley J, Summer L, et al. Toward meaningful quality and performance measures in part D. Washington, DC: Medicare Payment Advisory Commission (MedPAC), 2010 Oct [online]. Available from URL: http:// www.medpac.gov/documents/Oct10-PartDQualityandPer formanceMeasuresPartD- CONTRACTOR-RS.pdf [Accessed 2011 Mar 31]
53. Academy of Managed Care Pharmacy and National Committee for Quality Assurance. Developing a robust quality measurement approach for Medicare part D. Washington, DC, Alexandria (VA): National Committee for Quality Assurance, Academy of Managed Care Pharmacy, 2006 May [online]. Available from URL: http://www.ncqa.org/Portals/0/Publications/Resource%20Library/White%20 Papers/MedPartD.pdf [Accessed 2011 Mar 31]